All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Security
Security
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

The NHS-Galleri trial: What to expect in 2026 from the world’s first randomized controlled trial of a Multi-Cancer Early Detection test, Galleri®

As the multi-cancer early detection (MCED) field evolves, we and others have asserted that it is essential – in order for individuals to have confidence in a test – that it must have demonstrated…

Read the full article
Meredith Hemler8mo agoen

You might also wanna read

Galleri Blood Test Shows Promise in Detecting 50 Types of Cancer in Large Clinical Trial

The Galleri test looks for fragments of DNA that have broken off a tumour and are circulating in the blood.

bbc.com·9mo ago

Untitled

The news at 22:29:48 is: NHS trial of blood test offers 'genuine hope' for people with some cancers, A blood test designed to detect multipl

news.sky.com·1mo ago

Ultrasound Screening for Early Detection of Breast Cancer in Elderly Women: A Mixed Cluster-Individual RCT

Conditions : Breast Neoplasms; Early Detection of Cancer Interventions : Procedure: Standardized Breast Ultrasound Screening Sponsors : The

clinicaltrials.gov·3d ago

A Multicenter Randomized Open-Label Trial Evaluating MRD-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.

Conditions : NSCLC (Advanced Non-small Cell Lung Cancer); NSCLC (Non-small Cell Lung Cancer); NSCLC (Non-small Cell Lung Carcinoma); NSCLC;

clinicaltrials.gov·8d ago

Los nuevos diagnósticos de cáncer no aumentaron como se anticipaba después de la pandemia

Aunque los nuevos diagnósticos de cáncer volvieron en gran parte a los niveles prepandémicos en 2021, no reflejan los diagnósticos ausentes

NCI·1y ago

GE HealthCare and Mayo Clinic launch theranostics study to personalize prostate cancer treatment

CHICAGO, Ill. and ROCHESTER, Minn. — GE HealthCare and Mayo Clinic today announced the MI-BET (Molecular Imaging Biomarker-Based End of Ther

mayocl.in·8d ago

Comments

Sign in to join the conversation.

No comments yet. Be the first.